Jenifer Murphy
YOU?
Author Swipe
View article: Treatment of refractory obsessive–compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study
Treatment of refractory obsessive–compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study Open
Background Obsessive–compulsive disorder (OCD) is often challenging to treat and resistant to psychological interventions and prescribed medications. The adjunctive use of nutraceuticals with potential neuromodulatory effects on underpinni…
View article: Pilot-Testing of “Healthy Body Healthy Mind”: An Integrative Lifestyle Program for Patients With a Mental Illness and Co-morbid Metabolic Syndrome
Pilot-Testing of “Healthy Body Healthy Mind”: An Integrative Lifestyle Program for Patients With a Mental Illness and Co-morbid Metabolic Syndrome Open
Background: Metabolic syndrome and co-morbid physical health conditions are highly prevalent in people with a mental illness. Modifiable lifestyle factors have been targeted to improve health outcomes. Healthy Body Healthy Mind (HBHM) prog…
View article: Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses Open
(Reprinted with permission from American Journal of Psychiatry, 2016; 173:575-587).
View article: A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression
A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression Open
Major depression does not always remit. Difficult-to-treat depression is thought to contribute to the large disease burden posed by depression. Treatment-resistant depression (TRD) is the conventional term for nonresponse to treatment in i…
View article: An adjunctive antidepressant nutraceutical combination in treating major depression: Study protocol, and clinical considerations
An adjunctive antidepressant nutraceutical combination in treating major depression: Study protocol, and clinical considerations Open
Current treatment for major depressive disorder (MDD), a prevalent and disabling mental illness, is inadequate, with two-thirds of people treated with first-line antidepressants not achieving remission. MDD is for many a chronic condition,…